Market Research Logo

Latvia Pharmaceuticals & Healthcare Q3 2018

Latvia Pharmaceuticals & Healthcare Q3 2018

BMI View:

Cost-containment will remain a prominent theme within the Latvian pharmaceutical market, repressing drugmaker salesgrowth. With the introduction of a mandatory social health insurance system in 2019, these pressures will increase, offsetting thepositive impact of increased access to services and a reduction in out-of-pocket payments. As a result the small market will fail toprovide lucrative revenue growth opportunities relative to the majority of its EU counterparts.


BMI Industry View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Pharmaceuticals Risk/Reward Index
Latvia Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Grindeks
Olainfarm
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report